[TLX] YoY Quarter Result on 31-Dec-2024 [#Q4]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
31-Dec-2024
Financial Year
2024
Quarter
31-Dec-2024 [#Q4]
Profit Trend
QoQ- 227.39%
YoY- 95.79%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 594,244 281,713 136,049 4,686 3,606 1,667 195 280.29%
PBT 46,913 15,387 -27,919 -61,993 -35,157 -25,690 -10,524 -
Tax 8,674 -4,144 5,269 -13,997 -8,571 -8,192 1,884 28.95%
NP 38,239 19,531 -33,188 -47,996 -26,586 -17,497 -8,640 -
Tax Rate -18.49% 26.93% - - - - - -
Total Cost 556,005 262,182 169,237 52,682 30,192 19,165 8,835 99.31%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin 6.37 6.93 -24.39 -1,024.24 -737.27 -1,049.33 -4,430.77 -
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS 0.12 0.06 -0.10 -0.17 -0.10 -0.07 -0.04 -
EPS Diluted 0.11 0.06 -0.10 -0.17 -0.10 -0.07 -0.04 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.